Arcellx (ACLX) Tax Rate Growth (1y) (2024 - 2025)

Arcellx (ACLX) Tax Rate Growth (1y) (2024 - 2025) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 66,140.12 Bn 66,139.83 Bn -
2 Nanobiotix 1,912.79 Bn 1,912.73 Bn -
3 Akari Therapeutics 1,022.34 Bn 1,022.34 Bn -
4 BeOne Medicines 472.60 Bn 467.81 Bn 1.35 Bn
5 Vertex Pharmaceuticals 122.34 Bn 115.09 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 70.14 Bn 61.39 Bn 3.31 Bn
7 Belite Bio 62.79 Bn 62.79 Bn -
8 Argenx Se 56.19 Bn 51.00 Bn 1.41 Bn
9 Alnylam Pharmaceuticals 37.50 Bn 34.49 Bn 959.66 Mn
10 Arcellx 6.48 Bn 6.48 Bn -

Historic Data

Download Data
DateValue
Dec 31, 2025 331.00
Jun 30, 2025 106.00
Dec 31, 2024 -626.00
Sep 30, 2024 -88.00
Jun 30, 2024 -236.00